James Gordon

Stock Analyst at JP Morgan

(2.92)
# 1,559
Out of 4,931 analysts
9
Total ratings
83.33%
Success rate
21.77%
Average return

Stocks Rated by James Gordon

argenx SE
Aug 4, 2025
Maintains: Overweight
Price Target: $775$830
Current: $672.35
Upside: +23.45%
Grifols
Jun 17, 2025
Maintains: Neutral
Price Target: $7.6$10
Current: $10.65
Upside: -3.29%
Genmab
Aug 20, 2024
Downgrades: Neutral
Price Target: n/a
Current: $22.69
Upside: -
FibroGen
Apr 7, 2021
Upgrades: Neutral
Price Target: n/a
Current: $7.94
Upside: -